SANDOZ LISDEXAMFETAMINE CAPSULES
Identification of Sandoz Lisdexamfetamine Capsules
No description |
Google image searchProduct monograph
Active ingredient
lisdexamfetamine dimesylate, 10 MG
DIN: 02546248
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Schedule G (CDSA I)
Company: SANDOZ CANADA INCORPORATED
Date: 04-JUN-2024
ATC:
- N06 — PSYCHOANALEPTICS (ATC, ATC/DDD, )
- N06B — PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS (ATC, ATC/DDD)
- N06BA — Centrally acting sympathomimetics (ATC, ATC/DDD)
- N06BA12 — LISDEXAMFETAMINE (ATC/DDD)
Reference brand drug: Vyvanse
External Links for Sandoz Lisdexamfetamine Capsules
Search on Google
- Sandoz Lisdexamfetamine Capsules side effects
- Sandoz Lisdexamfetamine Capsules dosage
- lisdexamfetamine dimesylate side effects
- lisdexamfetamine dimesylate dosage
Sandoz Canada Incorporated
Go to Sandoz website to see drug product details. Sometimes you can find sandoz lisdexamfetamine capsules photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.